Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: A single-center report of 1166 kidney allograft recipients

Transplantation

Volumn 96, Issue 8, 2013, Pages 732-738

  Lee, John R ^a   Bang, Heejung ^b   Dadhania, Darshana ^a   Hartono, Choli ^a,c   Aull, Meredith J ^a   Satlin, Michael ^a   August, Phyllis ^a   Suthanthiran, Manikkam ^a   Muthukumar, Thangamani ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROGOSIN INSTITUTE   (United States)

Author keywords

Acute rejection; Bacteremia; Kidney transplantation; Urinary tract infection

Indexed keywords

COTRIMOXAZOLE;

ACUTE GRAFT REJECTION; ADULT; AGE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; COHORT ANALYSIS; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FOLEY BALLOON CATHETER; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; URETER STENT; URINARY TRACT INFECTION;

ACUTE DISEASE; AGE DISTRIBUTION; BACTEREMIA; FEMALE; GRAFT REJECTION; HUMANS; HYPERSENSITIVITY, DELAYED; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; STENTS; TRANSPLANTATION, HOMOLOGOUS; URETER; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 84886096444     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a04997     Document Type: Article

References (19)

1. de Souza RM, Olsburgh J. Urinary tract infection in the renal transplant patient. Nat Clin Pract Nephrol 2008; 4: 252.
2. Abbott KC, Oliver JD, Hypolite I, et al. Hospitalizations for bacterial septicemia after renal transplantation in the united states. Am J Nephrol 2001; 21: 120.
3. Silva M Jr, Marra AR, Pereira CA, et al. Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome. Transplantation 2010; 90: 581.
4. Foxman B. The epidemiology urinary tract infection. Nat Rev Urol 2010; 7: 653.
5. Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clin Transplant 2005; 19: 230.
6. Fiorante S, Lopez-Medrando F, Lizasoain M, et al. Systematic screening and treatment of asymptomatic bacteriuria in renal transplant recipients. Kidney Int 2010; 78: 774.
7. Iqbal T, Naqvi R, Akhter SF. Frequency of urinary tract infection in renal transplant recipients and effect on graft function. J Pak Med Assoc 2010; 10: 826.
8. Papasotiriou M, Savvidaki E, Kalliakmani P, et al. Predisposing factors to the development of urinary tract infections in renal transplant recipients and the impact on the long-term graft function. Ren Fail 2011; 33: 405.
9. Vidal E, Torre-Cisneros J, Blanes M, et al. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl Infect Dis 2012; 14: 595.
10. Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant 2006; 20: 401.
11. Fayek SA, Keenan J, Haririan A, et al. Ureteral stents are associated with reduced risk of ureteral complications after kidney transplantation: a large single center experience. Transplantation 2012; 93: 304.
12. Peterson PK, Ferguson R, Fryd DS, et al. Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem. Medicine (Baltimore) 1982; 61: 360.
13. Higgins RM, Bloom SL, Hopkin JM, et al. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation 1989; 47: 558.
14. Tolkoff-Rubin NE, Cosimi AB, Russell PS, et al. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis 1982; 4: 614.
15. Brennan DC, Daller JA, Lake KD, et al. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006; 355: 1967.
16. Kasiske BL, Zeier MG, Craig JC, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9: 1.
17. Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643.
18. Aull MJ, Dadhania D, Afaneh C, et al. Early corticosteroid withdrawal in recipients of renal allografts: a single-center report of ethnically diverse recipients and recipients of marginal deceased-donor kidneys. Transplantation 2012; 94: 837.
19. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria Van addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.